Transcat (TRNS) Competitors $76.41 +0.79 (+1.04%) Closing price 09/11/2025 04:00 PM EasternExtended Trading$76.41 0.00 (0.00%) As of 08:55 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TRNS vs. TXG, EYPT, ALNT, AEHR, CTKB, LAB, SENS, FEIM, QSI, and QTRXShould you be buying Transcat stock or one of its competitors? The main competitors of Transcat include 10x Genomics (TXG), Eyepoint Pharmaceuticals (EYPT), Allient (ALNT), Aehr Test Systems (AEHR), Cytek Biosciences (CTKB), Standard BioTools (LAB), Senseonics (SENS), Frequency Electronics (FEIM), Quantum-Si (QSI), and Quanterix (QTRX). These companies are all part of the "measuring and control equipment" industry. Transcat vs. Its Competitors 10x Genomics Eyepoint Pharmaceuticals Allient Aehr Test Systems Cytek Biosciences Standard BioTools Senseonics Frequency Electronics Quantum-Si Quanterix Transcat (NASDAQ:TRNS) and 10x Genomics (NASDAQ:TXG) are both small-cap measuring and control equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings. Do insiders and institutionals have more ownership in TRNS or TXG? 98.3% of Transcat shares are held by institutional investors. Comparatively, 84.7% of 10x Genomics shares are held by institutional investors. 2.8% of Transcat shares are held by company insiders. Comparatively, 9.4% of 10x Genomics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media refer more to TRNS or TXG? In the previous week, 10x Genomics had 8 more articles in the media than Transcat. MarketBeat recorded 15 mentions for 10x Genomics and 7 mentions for Transcat. Transcat's average media sentiment score of 1.35 beat 10x Genomics' score of 0.86 indicating that Transcat is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Transcat 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive 10x Genomics 5 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend TRNS or TXG? Transcat currently has a consensus price target of $112.20, suggesting a potential upside of 46.84%. 10x Genomics has a consensus price target of $13.65, suggesting a potential upside of 4.55%. Given Transcat's stronger consensus rating and higher probable upside, equities analysts plainly believe Transcat is more favorable than 10x Genomics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Transcat 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.6010x Genomics 1 Sell rating(s) 8 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has more risk & volatility, TRNS or TXG? Transcat has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500. Comparatively, 10x Genomics has a beta of 2, meaning that its share price is 100% more volatile than the S&P 500. Is TRNS or TXG more profitable? Transcat has a net margin of 4.64% compared to 10x Genomics' net margin of -13.13%. Transcat's return on equity of 6.66% beat 10x Genomics' return on equity.Company Net Margins Return on Equity Return on Assets Transcat4.64% 6.66% 5.09% 10x Genomics -13.13%-12.88%-10.03% Which has higher valuation & earnings, TRNS or TXG? Transcat has higher earnings, but lower revenue than 10x Genomics. 10x Genomics is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTranscat$278.42M2.56$14.52M$1.4353.4310x Genomics$610.78M2.66-$182.63M-$0.70-18.66 SummaryTranscat beats 10x Genomics on 10 of the 16 factors compared between the two stocks. Get Transcat News Delivered to You Automatically Sign up to receive the latest news and ratings for TRNS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TRNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRNS vs. The Competition Export to ExcelMetricTranscatINSTRU IndustryComputer SectorNASDAQ ExchangeMarket Cap$704.71M$2.99B$31.33B$10.07BDividend YieldN/A1.05%3.18%4.62%P/E Ratio53.4328.12441.1626.20Price / Sales2.563.081,822.4791.86Price / Cash17.7214.9336.4459.91Price / Book2.483.807.256.28Net Income$14.52M$91.11M$807.55M$270.85M7 Day Performance-2.26%1.73%3.17%3.58%1 Month Performance-7.98%0.85%5.22%6.67%1 Year Performance-38.04%26.60%24,265.93%27.74% Transcat Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRNSTranscat3.8254 of 5 stars$76.41+1.0%$112.20+46.8%-36.2%$704.71M$278.42M53.431,245News CoveragePositive NewsShort Interest ↑TXG10x Genomics3.3771 of 5 stars$13.93-0.2%$13.54-2.8%-40.9%$1.74B$610.78M-19.901,240News CoverageAnalyst ForecastEYPTEyepoint Pharmaceuticals2.106 of 5 stars$13.65-2.6%$26.86+96.8%+62.2%$965.67M$51.90M-5.09120Positive NewsALNTAllient3.0089 of 5 stars$45.76+0.5%$35.00-23.5%+146.4%$771.77M$529.97M53.212,525Positive NewsAEHRAehr Test Systems2.3243 of 5 stars$25.19-1.4%N/A+104.7%$764.63M$58.97M-193.7590Positive NewsCTKBCytek Biosciences2.075 of 5 stars$4.10+2.0%$5.60+36.6%-24.8%$511.44M$200.45M-82.00500Positive NewsLABStandard BioTools2.7882 of 5 stars$1.36+4.6%$1.55+14.0%-32.8%$496.59M$174.43M-4.25620Positive NewsInsider TradeHigh Trading VolumeSENSSenseonics1.6895 of 5 stars$0.44-3.0%$1.54+246.6%+15.6%$361.39M$25.47M-3.4190FEIMFrequency Electronics1.5256 of 5 stars$32.64+3.3%N/A+172.4%$308.08M$69.81M13.21200News CoverageEarnings ReportQSIQuantum-Si2.8111 of 5 stars$1.06-1.9%$3.48+227.8%+30.4%$218.70M$3.06M-1.56150News CoverageAnalyst ForecastQTRXQuanterix2.361 of 5 stars$4.52-0.7%$11.75+160.0%-60.3%$211.42M$137.42M-2.48460Positive News Related Companies and Tools Related Companies TXG Competitors EYPT Competitors ALNT Competitors AEHR Competitors CTKB Competitors LAB Competitors SENS Competitors FEIM Competitors QSI Competitors QTRX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TRNS) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCollege grad makes $64,000 a monthIt's easy to feel like you've missed out on the biggest stock market boom of the century. But if you want t...Stansberry Research | SponsoredUrgent: $3,452.50 a Month in Passive "AI Equity Checks"The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored2013 Bitcoin miner reveals his trading system (free)There are 18,347 cryptocurrencies in the market right now. 99% of them will fail. And trying to pick winner...Crypto Swap Profits | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Transcat, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Transcat With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRNS Stock Alerts